Level of adherence and associated factors to medication use in patients with diabetes mellitus

Mathar Mohideen Nagoor Thangam

doi:10.15253/2175-6783.20242594393

Authors

Mathar Mohideen Nagoor Thangam University of Tabuk. Tabuk, Saudi Arabia https://orcid.org/0000-0002-9822-8446

DOI:

https://doi.org/10.15253/2175-6783.20242594393

Keywords:

Medication Adherence; Diabetes Mellitus; Drug Therapy; Treatment Adherence and Compliance.

Abstract

Objective: to identify the level of medication adherence practices and associated factors among patients with diabetes mellitus. Methods: this cross-sectional descriptive study was conducted among diabetes mellitus patients at selected health centers in Tabuk, Saudi Arabia. A total of 218 participants were selected based on inclusion and exclusion criteria. The Medication Adherence Practice Scale with a maximum score of 50 was used to collect the data. Results: the mean medication adherence practice score was 28.64 ± 8.47, 65.1% of the participants had moderate adherence, 27.5% had high medication adherence, and 7.3% had low medication adherence. The multiple regression analysis showed that educational status (p=0.000), co-morbidity (p=0.001), monitoring of blood glucose (p=0.002), complications p=0.000), alternative therapies (p=0.000) and HbA1C level (p=0.000) were the significant predictors of medication adherence practice. Conclusion: this study identified the moderate medication adherence practices. Medication Adherence Practice was significantly associated with income, age, marital status, family size, educational status, occupation, years on diabetes medications, co-morbidity, medications for any other problems, number of antidiabetic drugs, source of medication adherence, regular monitoring, complications, and HbA1C level. Contributions to practice: studying the predictors of medication adherence practice of Diabetes Mellitus will enhance the health care interventions.

References

International Diabetes Federation. IDF Diabetes Atlas. Middle East and North Africa (MENA) Diabetes Report 2000-2045 [Internet]. 2021 [cited Oct 24, 2024]. Available from: https://diabetesatlas.org/data/en/region/4/mena.html

Pertiwi MV, Alfian R, Nita Y, Athiyah U. IAI special edition: medication adherence of diabetes mellitus patients in Indonesia: a systematic review. Pharm Educ. 2022;22(2):188-93. doi: https://doi.org/10.46542/pe.2022.222.188193

Waari G, Mutai J, Gikunju J. Medication adherence and factors associated with poor adherence among type 2 diabetes mellitus patients on follow-up at Kenyatta National Hospital, Kenya. Pan Afr Med J. 2018;29:82. doi: https://dx.doi.org/10.11604/pamj.2018.29.82.12639

AlQarni K, AlQarni EA, Naqvi AA, AlShayban DM, Ghori SA, Haseeb A, et al. Assessment of medication adherence in saudi patients with type II diabetes mellitus in Khobar city, Saudi Arabia. Front Pharm. 2019;10:1306. doi: https://dx.doi.org/10.3389/fphar.2019.01306

Asheq A, Ashames A, Al-Tabakha M, Hassan N, Jairoun A. Medication adherence in type 2 diabetes mellitus patients during Covid-19 pandemic: a cross-sectional study from the United Arab Emirates. F1000Res. 2021;10:435. doi: https://dx.doi.org/10.12688/f1000research.51729.2

Khunti N, Khunti N, Khunti K. Adherence to type 2 diabetes management. Br J Diabetes. 2019;19(2):99-104. doi: https://doi.org/dx.10.15277/bjd.2019.223

Alnaim MM, Alrasheed A, Alkhateeb AA, Aljaafari MM, Alismail A. Prevalence of microvascular complications among patients with type 2 diabetes mellitus who visited diabetes clinics in Saudi Arabia. Saudi Med J. 2023;44(2):211-7. doi: https://doi.org/10.15537/smj.2023.44.2.20220719

Zaki SM, El Karsh DS, Faden TM, Almghamsi LT, Fathaldin JO, Alhazmi OA. Diabetic foot complications in Saudi Arabia: a retrospective study. Cureus. 2024;16(2):e53531. doi: https://dx.doi.org/10.7759/cureus.53531

Kao C-C, Hsieh H-M, Lee DY, Hsieh K-P, Sheu S-J. Importance of medication adherence in treatment needed diabetic retinopathy. Sci Rep. 2021;11:19100. doi: https://dx.doi.org/10.1038/s41598-021-98488-6

Doya IF, Yahaya JJ, Ngaiza AI, Bintabara D. Low medication adherence and its associated factors among patients with type 2 diabetes mellitus attending Amana Hospital in Dar es Salaam, Tanzania: a cross-sectional study. Int Health. 2024;16(2):200-7. doi: https://doi.org/10.1093/inthealth/ihad042

Alomar MJ, Al-Ansari KR, Hassan NA. Comparison of awareness of diabetes mellitus type II with treatment’s outcome in term of direct cost in a hospital in Saudi Arabia. World J Diabetes. 2019;10(8):463-72. doi: https://doi.org/10.4239/wjd.v10.i8.463

Kingdom of Saudi Arabia. Saudi vision 2030. Vision 2030 Projects [Internet]. 2024 [cited Oct 24, 2024]. Available from: https://www.vision2030.gov.sa/en

Kim J, Combs K, Down J, Tillman F. Medication adherence: the elephant in the room. US Pharm [Internet]. 2018 [cited Oct 24, 2024];43(1)30-4. Available from: https://www.uspharmacist.com/article/medication-adherence-the-elephant-in-the-room

Alsanosi S, Hariri N, Alshanberi A, Alanazi I, Al-Eissa M, Alhindi Y. Adherence to chronic medications among type 2 diabetic patients in primary heath care centres: a cross-sectional study. Med Sci. 2022;26:ms387e2458. doi: https://doi.org/10.54905/disssi/v26i127/ms387e2458

Alsaidan AA, Alotaibi SF, Thirunavukkarasu A, ALruwaili BF, Alharbi RH, Arnous MM, et al. Medication adherence and its associated factors among patients with type 2 diabetes mellitus attending primary health centers of eastern province, Saudi Arabia. Medicina (Kaunas). 2023;59(5):989. doi: https://doi.org/10.3390/medicina59050989

Murwanashyaka JD, Ndagijimana A, Biracyaza E, Sunday FX, Umugwaneza M. Non-adherence to medication and associated factors among type 2 diabetes patients at Clinique Medicale Fraternite, Rwanda: a cross-sectional study. BMC Endocr Disord. 2022;22(1):219. doi: https://doi.org/10.1186/s12902-022-01133-0

Othman G, Ali F, Ibrahim MIM, Al-Worafi YM, Ansari M, Halboup AM. Assessment of anti-diabetic medications adherence among diabetic patients in Sana’a City, Yemen: a cross sectional study. J Pharm Res Int. 2020;32(21):114-22. doi: https://doi.org/10.9734/jpri/2020/v32i2130761

Islam SMS, Islam MDT, Uddin R, Tansi T, Talukderet S, Sarker F, et al. Factors associated with low medication adherence in patientswith Type 2 diabetes mellitus attending a tertiary hospital in Bangladesh. Lifestyle Med. 2021;2(4):e47. doi: https://doi.org/10.1002/lim2.47

Fallatah MS, Alghamdi GS, Alzahrani AA, Sadagah MM, Alkharji TM. Insights into medication adherence among patients with chronic diseases in Jeddah, Saudi Arabia: a cross-sectional study. Cureus. 2023;15(4):e37592. doi: https://dx.doi.org/10.7759/cureus.37592

Gu L, Wu S, Zhao S, Zhou H, Zhang S, Gao M, et al. Association of social support and medication adherence in Chinese patients with type 2 diabetes mellitus. J Pediatr Psychol. 2017;14(12):1522. doi: https://doi.org/10.3390/ijerph14121522

Wulandari N, Maifitrianti M, Hasanah F, Atika S, Dini PR. Medication adherence assessment among patients with type 2 diabetes mellitus treated polytherapy in Indonesian community health center: A cross sectional-study. J Pharm Bioallied Sci. 2020;12(Suppl 2):758-62. doi: https://dx.doi.org/10.4103/jpbs.JPBS_257_19

Rusminingsih E, Purnomo RT. Relationship of patient characteristics with medication adherence in type 2 DM. Indones J Global Health Res. 2022;4(3):603-10. doi: http://doi.org/10.37287/ijghr.v4i3.1316

Dinkova R, Marinov L, Doneva M, Kamusheva M. Medication adherence among patients with diabetes mellitus and its related factors—a real-world pilot study in Bulgaria. Medicina. 2023;59(7):1205. doi: https://doi.org/10.3390/medicina59071205

Alodhaib G, Alhusaynan I, Mirza A, Almogbel Y. Qualitative exploration of barriers to medication adherence among patients with uncontrolled diabetes in Saudi Arabia. Pharmacy (Basel). 2021;9(1):16. doi: http://doi.org/10.3390/pharmacy9010016

Rashidi A, Whitehead L, Kaistha P. Nurses’ perceptions of factors influencing treatment engagement among patients with cardiovascular diseases: a systematic review. BMC Nurs. 2021;20(1):251. doi: http://doi.org/10.1186/s12912-021-00765-2

Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: a systematic review and meta-analysis. Res Social Adm Pharm. 2019;15(9):1057-67. doi: https://dx.doi.org/10.1016/j.sapharm.2018.09.021

Alhammadi NA, Al Qahtani AA, Hosiky MF, Al Shahrani FS, Al Shehri SM, Al Ghamdi MA, et al. Public awareness of diabetes complications and its effect on treatment compliance in Asir region, Saudi Arabia. J Family Med Primary Care. 2022;11(11):6812-7. doi: https://dx.doi.org/10.4103/jfmpc.jfmpc_422_22